placeholder image
I. Ahmed All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Safety of continuing warfarin therapy in patients undergoing cardiac resynchronization therapy device implantation
    2017
  • Perioperative management of anticoagulation in patients on warfarin therapy undergoing surgery for cardiac implantable electronic devices
    2013
  • Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels. 
    American Journal of Medicine. 2012
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients. 
    European Journal of Echocardiography. 2011
  • Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation. 
    Journal of Interventional Cardiac Electrophysiology. 2010
  • Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. 
    Heart rhythm. 2010
  • Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. 
    Heart International. 2010
  • Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation. 
    BMJ Case Reports. 2009
  • How reliable is an effective orifice area indexed chart?. 
    Journal of Heart Valve Disease. 2009
  • Malignant hypertension and acute aortic dissection associated with caffeine-based ephedra-free dietary supplements: a case report. 
    Cases journal. 2009
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). 
    Journal of Cardiothoracic Surgery. 2009
  • Sudden cardiac arrest in apical hypertrophic cardiomyopathy. 
    BMJ Case Reports. 2009
    • Review
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis [review, meta-analysis]. 
    Interventional Cardiology. 2011
    • Abstract
  • Chronic kidney disease is a significant risk factor of pocket hematoma formation after pacemaker and implantable cardioverter-defibrillator placement independent of anticoagulation and antiplatelet agents [abstract]. 
    Journal of the American College of Cardiology. 2010
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [abstract]. 
    Heart rhythm. 2010
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [abstract]. 
    Journal of the American Society of Echocardiography. 2010
  • Obesity and pulmonary hypertension are independent risk factors for postoperative paraoxysmal atrial fibrillation after heart valve replacement surgery [abstract]. 
    Heart rhythm. 2010
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [abstract]. 
    Circulation. 2009
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [abstract]. 
    Circulation. 2009
    • presentations
    Presentation
  • A comparison of three different peri-operative anticoagulation strategies during cardiac resynchronization therapy implantation [presentation], Robert Hebbel Fifteenth Annual Research Day
  • Association and severity of coronary artery disease and carotid artery disease in patients with aortic stenosis [presentation], University of Minnesota 11th Annual Robert Hebbel Research Day
  • Chronic kidney disease is a significant predictor of pocket hematoma complications after pacemaker and implantable cardioverter defibrillator placement independent of anticoagulation and antiplatelet agents [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • Continuation of warfarin is superior to holding warfarin with or without bridging therapy in patients undergoing pacemaker and defibrillator placement [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • How reliable is an effective orifice area indexed chart [presentation]?, University of Minnesota 11th Annual Robert Hebbel Research Day
  • Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • Predictors and prognosis of worsening renal function in patients hospitalized with acute diastolic heart failure and treated with intravenous furosemide [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB) [presentation], University of Minnesota 11th Annual Robert Hebbel Research Day
  • Safety of cardiac resynchronization therapy device implantation in patients with uninterrupted chronic warfarin therapy [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
  • Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a systematic review and meta-analysis [presentation], University of Minnesota 12th Annual Robert Hebbel Research Day
    • Contact
    full name
  • I. Ahmed
    • Quick Info
     
    Collaboration